ThromboGenics Business Update H1 2014 Aug 28, 2014 11:56AM
Nicox first half 2014 financial results Aug 28, 2014 01:37AM
Pharmaceutical Executive Joins Mesoblast As Chief Financial Officer Aug 24, 2014 09:16PM
PM360 Announces 2014 Trailblazer Award Finalists Aug 20, 2014 09:06AM
ThromboGenics' JETREA Receives Positive Recommendation from Scottish Medicines Consortium (SMC) Aug 11, 2014 11:52AM


Aug 11, 2014 01:35AM Nicox announces changes to its Board of Directors
Jul 31, 2014 10:33AM ThromboGenics' JETREA Nominated for 2014 Prix Galien USA
Jul 30, 2014 10:39AM Envisia Therapeutics Announces Appointments to Board of Directors
Jun 24, 2014 02:12AM ThromboGenics Provides Update on Strategic Review Process
Jun 23, 2014 02:30AM Definiens Secures € 15 Million for Tissue Phenomics-based Cancer Diagnostics
Jun 18, 2014 09:00AM Big Pharma Becomes a Smaller Employer While Biotech Booms
Jun 4, 2014 10:30AM Global Ophthalmic Drugs Market Worth $9.7bn by 2024, Says a New Research Report Available at LifeScienceIndustryResearch.com
Jun 2, 2014 08:00AM Ohr Pharmaceutical Announces Closing of SKS Ocular Acquisition; Strengthens Executive Management Team
Apr 9, 2014 06:34AM Novartis AG (NVS) Novartis Names New Division Leaders for Sandoz, Alcon
Dec 18, 2013 02:12PM Perrigo (PRGO) Names CEO Papa as Chairman; Announces Director Slate
Nov 22, 2013 07:05AM Novartis (NVS) Announces $5B Buyback Plan; Updates on Long-Term Expectations
Jan 18, 2013 07:43AM Novartis' (NVS) Alcon Receives Positive CHMP Opinion for Jetrea as VMT Treatment
Mar 16, 2012 07:04AM Novartis' (NVS) Unit Gets Exclusive Rights to Ocriplasmin Outside the U.S.
Oct 25, 2011 08:20AM Novartis (NVS) Misses Q3 EPS by 6c, Sales Miss Expectations, Offers Q4 Outlook
Sep 13, 2011 06:44AM Novartis (NVS) Updates on Long-Term Strategy; Comments on Plans for Alcon
Dec 17, 2010 05:43PM Top 10 News Items 12/13-12/17: $858B Tax-Cut Bill Signed; Best Buy Tanks on Concerning Q3 Results; Visa, MasterCard Tumble As Durbin Strikes Back